Immunological tests have been applied extensively to the study of chronic inflammatory disease of the liver and its pathogenesis, and have now gained an accepted place in clinical diagnosis. They have been used particularly in investigation of jaundice and cholestasis, in distinguishing the various types of cirrhosis and in their differentiation from more acute forms of hepatocelullar disorder. The recently described Australia antigen (virus-associated antigen) has at last made possible certain identification of a viral aetiology in some instances of acute and chronic liver disease.
Raised levels of serum gamma globulins occur in many acute and chronic hepatic conditions. In acute inflammation, as in virus hepatitis and cholangitis, a modest increase occurs 7 to 14 days after onset, but returns to normal within a few months and persistence of high levels may indicate transition to chronic liver disease and the development ofcirrhosis. In this condition, serum protein electrophoresis may show fJ--'Y fusion due to increase in the faster globulins (Yl) whereas a narrow distinct gamma peak is characteristic of active chronic hepatitis (juvenile cirrhosis) and consists essentially of slower Y.
globulins (Hobbs, 1966) . The electrophoretic fJ and Y regions are now known to contain the five immunoglobulin classes IgG, 19A, IgM, IgD, and IgE (Terry, 1967) while the first four of these can be estimated simply and quantitatively by single radial immunodiffusion on agar plates (Mancini et al., 1965) . In acute hepatitis a rapid rise in serum IgM level may occur but usually returns to normal within several weeks, while changes in IgA and IgG levels occur much less frequently and are seldom marked (Lee, 1965; LoGrippo et al., 1966; Wollheim, 1968; Walker et al., 1970a) . Detailed epidemiological studies (Krugman et al., 1967) have demonstrated the presence of two distinct types of virus hepatitis: 'MS-1' type (typical infectious hepatitis) and 'MS-2' type (which resembles serum hepatitis), and it has been suggested that IgM elevations are much less marked and less common in the latter disease (Wollheim, 1968; Giles and Krugman, 1969b ). This has not been borne out in recent work where it was also found that similar immunoglobulin changes occurred in hepatitis associated with infectious mononucleosis (Walker et al., 1970a) . It is of interest that elevated IgM levels appeared to correlate with abnormal thymol turbidity tests in one study (Wollheim, 1968) confirming the in vitro experiments of Hartmann et al. (1963) with addition of pure IgM to normal serum.
Pronounced or protracted IgG elevation suggests the presence of underlying chronic hepatocellular disease, or progression to this condition. Extreme hypergammaglobulinaemia is characteristically seen in the active phase of juvenile cirrhosis and there is frequently a substantial increase in serum IgG concentration. IgA elevation has been described as typical of portal cirrhosis, particularly in association with chronic alcoholism (Lee, 1965) . In Primary biliary cirrhosis the IgM fraction is usually raised and it has been claimed that isolated elevation of this immunoglobulin may be used in differentiation from secondary biliary and other forms of cirrhosis (Hobbs, 1967) . In a recent study (Feizi, 1968) , however, it was demonstrated that in all types of cirrhosis the changes were rarely selective, and varying degrees of elevation were found in each of the three major immunoglobulin classes (lgG, 19A, and IgM) . IgM levels were in fact raised in 81 % of primary biliary cirrhosis cases but elevations were also seen in 21 % of patients with main bile-duct obstruction. High values of serum IgM have also been found by others in cirrhosis due to the latter cause (Paronetto et al., 1964) . The diagnostic value of immunoglobulin estimations in the chronic liver diseases is thus very limited. IgD levels appear to be normal in all the hepatic disorders so far studied, while 19E determinations have not as yet been reported in the context of liver disease.
In the majority of cases of hypergammaglobulinaemia the globulins are polyclonal, with chemically distinct molecules showing the entire range of different light chains on starch-gel electrophoresis in urea medium. In a few isolated cases of cirrhosis M-bands with single light-chains, characteristic of monoclonal garnmopathy, have been described (Hobbs, 1966) . Immunoglobulins are not produced in the normal liver but in chronic hepatic disease they have been identified in the lymphoid and plasma cells infiltrating portal areas and liver parenchyma. IgG appears to be the predominant immunoglobulin synthesised by mesenchymal cells in the liver in active chronic hepatitis (Paronetto et al., 1962) while lymphoid aggregates around damaged bile ductules in primary biliary cirrhosis produce mainly IgM (Paronetto et al., 1964) .
The elevated serum immunoglobulin values in some cases of chronic liver disease are associated 93 with circulating antibodies directed against various tissues and tissue components. The earliest work in this field employed standard complement fixation tests with saline suspensions of extracts or homogenates of various tissues and organs, including the liver. Attention was initially focused on studies in acute liver diseases, particularly viral hepatitis, in an attempt to develop a diagnostic test for this condition. Positive reactions were obtained over a wide spectrum of liver disorders, however, and it became apparent that they resulted from interactions between various tissue-cell components and auto-antibodies in the serum. This is the reaction which has been called the 'auto-immune complement fixation test' (AICF). This procedure is now carried out in perspex trays with the aid of the Takatsy microtitration apparatus for making serial dilutions, and is relatively easy to perform. The test, however, is nonspecies and non-organ specific and no serum antibody reacting exclusively with the liver has been so far identified. It nevertheless has become clear that high titres of these non-organ specific antibdodies in the serum are confined virtually to three chronic liver conditions, namely active chronic hepatitis, cryptogenic cirrhosis (cirrhosis of unknown cause) and primary biliary cirrhosis (Doniach et al., 1966) , and the significance of this is more fully discussed subsequently. The latex-Ffl fixation (agglutination) reaction, which can now be performed in a matter of minutes in the form of a slide test with commercially available globulin-coated latex particles, has been used in liver disease as an aid to diagnosis (Dresner and Trombly, 1959; Atwater and Jacox, 1963 ) but positive reactions occur in a wide variety of disorders and the test should probably be abandoned as a diagnostic procedure, as the overlap in the various conditions is too great. This test detects rheumatoid factors in the serum; these are antibodies directed against IgG (Bonomo et al., 1963) .
In recent years, the introduction of the immunofluorescent technique (Coons and Kaplan, 1950; Coons, 1956 ) has given new impetus to the study of serological changes in liver disorders and has led to important discoveries. Antibodies can be made fluorescent by chemically attaching to them a fluorescent dye, the most generally used being the isocyanate or isothiocyanate of fluorescein itself. Such fluorescent antibodies can be used to demonstrate both antigen and antibody in tissue sections, cell suspensions or smears when these are examined microscopically under ultraviolet light. The so-called 'double layer' technique is particularly suitable for the study of serum antibodies in liver disease. For this test, fixed and unfixed cryostat sections of thyrotoxic thyroid gland, human gastric fundal mucosa and human and rat kidney are incubated in a moist box for 30 min. at room temperature with two drops of the serum from the patient to be tested, together with two drops of fresh normal human serum as a source of complement. A conjugate of fluorescein with rabbit anti-human-y-globulin is then applied for 30 min., the sections being washed for 15 min. after each step of the procedure. High titres of serum antibodies, detected by this method, occur in the same three chronic liver diseases givingstrongly positive complement fixation reactions (Doniach et al., 1966) . Thus antibodies directed against cell nuclei are present in 75 % of cases of active chronic hepatitis, in 46 %of primary biliary cirrhosis patients and in 38 % of cases of cryptogenic cirrhosis. In active chronic hepatitis there is a correlation between serum antibody titres and gamma-globulin levels. Antibodies reacting with smooth muscle fibres (Johnson et al., 1965) occur in some 70 % of active chronic hepatitis cases while their incidence in the two other chronic liver conditions is around 35%. Other reactions described in active chronic hepatitis produce staining, on immunofluorescence, of renal glomerular cells (Whittingham et al., 1966) and 'bile canaliculi' (Johnson et al., 1966) . The significance of these antibodies is still undergoing evaluation. They will probably prove of use in diagnosis in conjunction with other tests (Walker et aI., 1967) . High and persistent titres of all these tissue antibodies are confined to the same three chronic liver disorders, while they do not occur in cirrhosis due to known metabolic disturbances (e.g. alcoholism, haemochromatosis). This suggests that the antibodies do not arise solely as a result of tissue damage with subsequent auto-immunisation. Transient, lowtitre smooth muscle (fluorescent) and complement fixation (AICF) reactions are, however, not infrequently encountered in acute viral hepatitis and in hepatitis due to glandular fever (Walker et al., 1970a) . These disappear upon recovery from the acute illness. The polarisation of tissue antibodies to three particular diseases also suggests they might share a common underlying pathogenetic process, although the exact relationship of this to autoantibody production is obscure (Doniach and Walker, 1969) . It is not believed that the tissue antibodies themselves, which are non-organ specific, play a direct causative role in production of the liver disorders in which they occur.
Of even greater diagnostic help is the non-organ specific, non-species specific serum antibody (Walker et al., 1965) directed against a component of the mitochondrial inner membranes of a variety of tissue cells (Berg et al., 1967) . Evaluation in different centres has shown that this test is positive in 79-94 % of primary biliary cirrhosis patients and in less than 3 % of cases of main bile-duct obstruction . Small variations in incidence can probably be accounted for by technical differences in the methods used. Titres of mitochondrial antibodies in primary biliary cirrhosis vary from trace amounts to over 1 in 6,000, but bear no relation to the duration of the disease. Negative reactors are in no way distinguishable from those who have high titres of antibody. The antibody does not occur in the bile of these patients. Although frequently associated with elevation of the serum IgM level, the antibody is usually polyclonal . It occurs infrequently and in low titres only in other non-cirrhotic forms of cholestasis (e.g. virus hepatitis, pericholangitis in colitis, cholestatic drug jaundice) and thus a strongly positive reaction is of great help in distinguishing primary biliary cirrhosis from these disorders which may closely simulate it. Again, the only other liver disorders where significant titres of this antibody are found are active chronic hepatitis and cryptogenic cirrhosis, and some of the cases where the antibody occurs (around 25 % incidence in both disorders) show certain clinical and histological features resembling primary biliary cirrhosis (Doniach et al., 1970) . Although the antibody occurs in less than 1 % of the general population, interpretation of a positive test should be guarded in the presence of collagenosis or other diseases where immune mechanisms are implicated (e.g, thyroiditis) as these patients may show high titres of this and other tissue antibodies (Walker et al., 1970b) . It is of interest that some of these patients have abnormalities of biochemical tests of hepatic function (in particular, elevation of serum alkaline phosphatase levels and abnormal bromsulphthalein retention) in the absence of clinical evidence of liver disease. Histological changes on liver biopsy in some of the cases reveals a hepatitis with portal inflammation and features of resemblance to both active chronic hepatitis and to primary biliary cirrhosis. Transient low titres of mitochondrial antibodies are seen in certain cases of drug jaundice and virus hepatitis but disappear upon clinical recovery (Walker et al., 1967 , Rodriguez et al., 1969 .
Mention must finally be made of the association between virus hepatitis and the recently discovered Australia antigen (Blumberg et al., 1968) . This is now generally accepted and investigations by Giles et al. (1969a) indicate that this association is with serum ('MS-2') hepatitis and not with infectious ('MS-l ') hepatitis. The antigen can be detected in the blood of some patients with hepatitis, generally for a few weeks after the onset of symptoms. It can be seen in the blood, with the aid of electron microscopy, in the form of small particles about 22 nm in diameter and in some serum specimens long forms of the same width can also be seen. The Australia antigen can also be demonstrated by two-dimensional immunodiffusion tests (Prince, 1968) on agar gel plates. Precipitation lines form when a positive serum specimen containing antigen reacts with a known serum containing antibody, the latter usually being obtained from a poly-transfused patient. Known antigen-positive sera are also used as controls. The antigen may also be demonstrated in blood samples by standard complement-fixation methods. Application of these techniques will doubtless do much to clarify the aetiology of a proportion at least of cases of acute and chronic inflammatory disease of the liver, and the relationship of these disorders to other observed immunological phenomena.
